Cabergoline-Related Severe Restrictive Mitral Regurgitation
NEJM 353:1974-1975, Rosen,C.J., 2005
Heart Valvular Disease in Patients with Parkinson's Disease Treated with High-Dose Pergolide
Neurol 61:859-861, VanCamp,G.,et al, 2003
Intravenous Dihydroergotamine for Inpatient Management of Refractory Primary Headaches
Neurol 77:1827-1832, Nagy, A.J.,et al, 2011
Valvular Heart Disease and the Use of Dopamine Agonists for Parkinsons Disease
NEJM 356:39-46, Zanettini,R.,et al, 2007
Dopamine Agonists and the Risk of Cardiac Valve Regurgitation
NEJM 356:29-38, Schade,R.,et al, 2007
Treatment of Parkinson's Disease with Pergolide and Relation to Restrictive Valvular Heart Disease
Lancet 363:1179-1183, Van Camp,G.,et al, 2004
The Emergency Management of Headaches
The Neurologist 9:93-98, Green,M.W., 2003
The Association of the Combination of Sumatriptan and Methysergide in Myocardial Infarction in a Premenopausal Woman
Arch Int Med 159:511-513, Liston,H.,et al, 1999
Valve Disease Associated with Ergot Alkaloid Use:Echocardiographic and Pathologic Correlations
Ann Int Med 117:50-52, Redfield,M.M.,et al, 1992
Symptomatic and Prophylactic Treatment of Migraine and Tension-Type Headache
Neurol 42:16-21, Schulman,E.A.&Silberstein,S.D., 1992